Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Acta Pharmaceutica Sinica
>
2021
>
56
>
2
Volume:
56
Issue:
2
1. Pharmacokinetic/pharmacodynamic modeling of the antitumor action of bispecific CD3/EpCAM antibody M701 in human colorectal cancer xenograft mice
Page:538—544
2. Updated research progress of selective PPAR
γ
modulators
Page:352—359
3. Research progress on small molecule kinase inhibitors
Page:414—431
4. Metabolic module identification and biological mechanism of Xiaoyaosan for treatment of depression
Page:528—537
5. Current status and future of drugs targeting platelets-tumor cells interactions
Page:360—367
6. Progress in tumor microenvironment responsive nano-platforms for cancer theranostics
Page:465—475
7. Research progress in multi-targeted anti-tumor natural products
Page:403—413
8. Preparation and anti-tumor activity of a novel antibody-drug conjugate 607-LDM
Page:496—502
9. Research progress on metabolism and efficacy of small molecular prodrug nanosystems responsive to tumor redox microenvironment
Page:476—486
10. Lead compound optimization strategy (8) - drug transporters and related drug design strategies
Page:432—444
11. Mechanistic study on the solubility enhancement of puerarin by coamorphous technology
Page:585—592
12. Advances in the optimization of the linker in proteolysis-targeting chimeras (PROTAC)
Page:445—455
13. Research advances on the protective effects and mechanism of salvianolic acids against ischemic heart disease
Page:368—373
14. Preparation and enhanced photodynamic therapy of supramolecular nanoparticles to overcome tumor hypoxia
Page:593—603
15. Research advances in the effect and utilization of protein corona on the circulation of nanoparticles
in vivo
Page:487—495
16. Identification and application of biomarkers in life cycle of drugs
Page:456—464
17. Cloning and bioinformatic analysis of the 3-ketoacyl-CoA synthase gene in
Coix lacryma-jobi
L.
Page:610—617
18. Complete plastid genomes of
Bupleurum chinense
DC. and
B. boissieuanum
H. Wolff, with comparative and phylogenetic analyses of medicinal
Bupleurum
species
Page:618—629
19. Simultaneous quantitative analyses of six components in
Astragalus membranaceus
based on HPLC-CAD and quantitative analysis of multi-components with a single-marker
Page:557—564
20. Value assignment study on bioactivity of monoclonal antibody working reference standard
Page:565—569
21. Identification of small molecule sirtuin-1 inhibitors for treating acute myeloid leukemia based on molecular docking, quantitative structure-activity relationships and molecular dynamics
Page:545—552
22. Preparation, characterization and improved solubility of ticagrelor salts
Page:570—576
23. Recent advancement in targeting the KRAS-G12C mutant for cancer therapy
Page:374—382
24. Construction of a drug screening model for miscarriage from induced pluripotent stem cells
in vitro
Page:503—510
25. A new dimeric benzylisoquinoline alkaloid from
Corydalis yanhusuo
Page:553—556
26. Cloning and expression analysis of chalcone isomerase from
Aquilaria sinensis
Page:630—638
27. Rutaecarpine exerted anti-osteroporosis
Page:511—519
28. Bruceantin inhibits proliferation, migration and invasion of non-small cell lung cancer H1299 cells by up-regulating miR-29a-3p
Page:520—527
29. Synaptic pruning mediated by glia in Alzheimer's disease
Page:383—390
30. Role of gut microbiota in the treatment of ulcerative colitis with traditional Chinese medicine
Page:391—402
31. Establishment of a cocrystal characterization method for sacubitril valsartan sodium
Page:577—584
32. Preparation and targeting capability of corona forming in human ovarian plasma
Page:604—609
33. First-in-class small molecule drugs in 2020
Page:341—351